APPLIED BIOCODE TAIWAN LTD.
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
Providing a multiplex diagnostic platform focused on the research and development of diagnostic reagents, diagnostic instruments, and the manufacturing of technology platforms.
The content above was translated by Ai
Founded Year
2015
Unified Business No.
42830582
Status
Active
Number of Employees
80
Total Paid-in
Capital
103,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
APPLIED BIOCODE TAIWAN focuses on the design, development, and manufacturing of multiplex diagnostic products marketed globally under the Applied BioCode brand. Its core Barcoded Magnetic Bead (BMB) technology offers up to 4,096 unique digital codes with exceptional decoding accuracy, enabling rapid development of multiplex nucleic acid and protein assays. Its in vitro diagnostic products focus on infectious diseases, including gastrointestinal, respiratory, and COVID-19 testing, with FDA-cleared solutions and ongoing expansion into fungal and antimicrobial resistance detection.
The content above was translated by Ai
